Dianhydrodulcitol

去水卫矛醇

Report date: 2022/12/16 10:28:04
NME

Base Information

Drug NameDianhydrodulcitol
Drug Alias Name卫康醇DAGGalacititol二去水卫矛醇Diepoxydulcitol +[11] 
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionAlkylating agentsDNA damage stimulantsCell cycle inhibitors
TargetsNot applicable
Therapy Area/IndicationsLung NeoplasmsBrain NeoplasmsOvarian Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGuangxi Wuzhou Pharmaceutical (Group) Co LtdDelmar Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesKintara Therapeutics IncGuangxi Wuzhou Pharmaceutical (Group) Co Ltd
Inactive CompaniesDelmar Pharmaceuticals Inc
Active IndicationsLung NeoplasmsBrain NeoplasmsGlioblastoma +[5] 
Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeL01
Related LinksN/A